KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $15.18 $22.42 Friday, 26th Apr 2024 RGNX stock ended at $16.19. This is 0.81% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.58% from a day low at $15.72 to a day high of $16.44.
90 days $11.83 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Apr 26, 2024 $16.20 $16.44 $15.72 $16.19 298 490
Apr 25, 2024 $15.80 $16.16 $15.29 $16.06 584 704
Apr 24, 2024 $15.96 $16.39 $15.60 $16.04 334 414
Apr 23, 2024 $15.67 $16.28 $15.52 $15.90 345 845
Apr 22, 2024 $15.89 $16.10 $15.18 $15.64 403 987
Apr 19, 2024 $16.01 $16.26 $15.32 $15.69 542 748
Apr 18, 2024 $16.75 $16.81 $16.05 $16.11 541 256
Apr 17, 2024 $17.59 $17.99 $16.99 $17.03 387 727
Apr 16, 2024 $17.83 $18.24 $17.48 $17.50 242 544
Apr 15, 2024 $18.07 $18.65 $17.82 $18.02 339 709
Apr 12, 2024 $19.02 $19.38 $17.63 $18.09 542 723
Apr 11, 2024 $19.12 $19.12 $18.48 $19.02 251 388
Apr 10, 2024 $18.23 $19.04 $18.18 $18.85 592 739
Apr 09, 2024 $19.20 $19.77 $18.73 $19.01 248 316
Apr 08, 2024 $19.22 $19.34 $18.79 $19.19 274 180
Apr 05, 2024 $18.94 $19.87 $18.60 $19.17 411 366
Apr 04, 2024 $20.32 $20.77 $19.06 $19.15 612 186
Apr 03, 2024 $20.02 $20.65 $19.83 $20.25 518 225
Apr 02, 2024 $21.17 $21.19 $20.16 $20.29 525 477
Apr 01, 2024 $21.08 $21.57 $20.65 $21.53 529 509
Mar 28, 2024 $22.33 $22.42 $20.94 $21.07 487 038
Mar 27, 2024 $21.79 $22.34 $21.43 $22.18 457 108
Mar 26, 2024 $21.88 $22.30 $21.47 $21.67 328 348
Mar 25, 2024 $21.81 $22.12 $21.13 $21.59 279 425
Mar 22, 2024 $22.49 $22.81 $21.75 $21.78 270 502
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT